BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1016 related articles for article (PubMed ID: 30259310)

  • 1. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D; ElAsmar N; Arafah BM
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH-independent hypercortisolism.
    Morelli V; Minelli L; Eller-Vainicher C; Palmieri S; Cairoli E; Spada A; Arosio M; Chiodini I
    J Endocrinol Invest; 2018 Apr; 41(4):485-493. PubMed ID: 29151238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of peri-operative dexamethasone administration on the normal hypothalamic pituitary adrenal response to major surgical procedures.
    El-Sibai K; Rajpal A; Al-Aridi R; Selman WR; Arafah BM
    Endocrine; 2017 Oct; 58(1):134-142. PubMed ID: 28865040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical Cushing's syndrome.
    Reincke M
    Endocrinol Metab Clin North Am; 2000 Mar; 29(1):43-56. PubMed ID: 10732263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome.
    Doherty GM; Nieman LK; Cutler GB; Chrousos GP; Norton JA
    Surgery; 1990 Dec; 108(6):1085-90. PubMed ID: 2247834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of hypothalamic-pituitary-adrenal suppression following curative surgery for Cushing's syndrome due to adrenal adenoma.
    Gordon D; Semple CG; Beastall GH; Thomson JA
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):166-70. PubMed ID: 3030034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome.
    Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K
    J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unilateral adrenalectomy for cortisol producing adenoma: prolonged suppression of the hypothalamus-pituitary-adrenal axis].
    Arteaga E; González G; López JM; Rodríguez JA; Codner E
    Rev Med Chil; 1990 Apr; 118(4):426-9. PubMed ID: 1966792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses.
    Young WF; du Plessis H; Thompson GB; Grant CS; Farley DR; Richards ML; Erickson D; Vella A; Stanson AW; Carney JA; Abboud CF; Carpenter PC
    World J Surg; 2008 May; 32(5):856-62. PubMed ID: 18074172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive clinical experience: Hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess.
    Hurtado MD; Cortes T; Natt N; Young WF; Bancos I
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):721-733. PubMed ID: 29968420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
    Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
    Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.
    Yener S; Demir L; Demirpence M; Mahmut Baris M; Simsir IY; Ozisik S; Comlekci A; Demir T
    Endocrine; 2017 May; 56(2):308-316. PubMed ID: 28247312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.